BNP Paribas Financial Markets’s Loxo Oncology, Inc LOXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-1,851
| Closed | -$259K | – | 4494 |
|
|
2018
Q4 | $259K | Sell |
1,851
-1,060
| -36% | -$161K | ﹤0.01% | 2016 |
|
|
2018
Q3 | $497K | Buy |
2,911
+869
| +43% | +$146K | ﹤0.01% | 2030 |
|
|
2018
Q2 | $354K | Sell |
2,042
-2,822
| -58% | -$424K | ﹤0.01% | 2166 |
|
|
2018
Q1 | $561K | Buy |
4,864
+77
| +2% | +$8.19K | ﹤0.01% | 2132 |
|
|
2017
Q4 | $403K | Buy |
4,787
+2,289
| +92% | +$191K | ﹤0.01% | 2595 |
|
|
2017
Q3 | $230K | Buy |
2,498
+254
| +11% | +$19.7K | ﹤0.01% | 2387 |
|
|
2017
Q2 | $180K | Buy |
2,244
+2,194
| +4,388% | +$122K | ﹤0.01% | 2512 |
|
|
2017
Q1 | $2.1K | Sell |
50
-694
| -93% | -$28.6K | ﹤0.01% | 3533 |
|
|
2016
Q4 | $23.9K | Sell |
744
-197
| -21% | -$5.05K | ﹤0.01% | 3112 |
|
|
2016
Q3 | $24.6K | Buy |
941
+387
| +70% | +$10.1K | ﹤0.01% | 2777 |
|
|
2016
Q2 | $12.8K | Buy |
+554
| New | +$13.8K | ﹤0.01% | 2778 |
|
|
2016
Q1 | – | Sell |
-1,732
| Closed | -$49.3K | – | 3344 |
|
|
2015
Q4 | $49.3K | Buy |
1,732
+65
| +4% | +$1.74K | ﹤0.01% | 2820 |
|
|
2015
Q3 | $29.1K | Buy |
1,667
+1,019
| +157% | +$19.9K | ﹤0.01% | 3176 |
|
|
2015
Q2 | $11.7K | Buy |
648
+571
| +742% | +$7.8K | ﹤0.01% | 3298 |
|
|
2015
Q1 | $959 | Buy |
+77
| New | +$959 | ﹤0.01% | 3557 |
|
Other funds holding LOXO
BNP Paribas Financial Markets's LOXO Position: Q1 2019 in Review
BNP Paribas Financial Markets sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 1,851 shares — an estimated $259K sold.
BNP Paribas Financial Markets first reported a position in LOXO in Q1 2015 and held it in 15 quarters. The position peaked at $561K in Q1 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.
- BNP Paribas Financial Markets reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
- BNP Paribas Financial Markets sold 1,851 Loxo Oncology, Inc shares in Q1 2019, an estimated $259K.
- BNP Paribas Financial Markets first reported a position in Loxo Oncology, Inc in Q1 2015 and held it in 15 quarters.
- BNP Paribas Financial Markets's Loxo Oncology, Inc position peaked at $561K in Q1 2018.
- 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2019, filed 25 Apr 2019.